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Abstract
Objective: The aim of this study was to determine whether intra-abdominal pressure (IAP) monitoring using the
FoleyManometer (Holtech Medical, Charlottenlund, Denmark) increases the risk of urinary tract infection (UTI).
Design: A retrospective database review was conducted.
Setting: The study was conducted in the 12-bed medical intensive care unit of ZNA Stuivenberg Hospital
(Antwerp, Belgium), a tertiary hospital.
Patients: There were 5,890 patients admitted to the medical intensive care unit of which 1,097 patients underwent
intrabladder pressure (IBP) monitoring as estimate for IAP.
Interventions: Crude and adjusted UTI rates were compared among patients undergoing IAP measurements with
three different intrabladder methods: a modified homemade technique, a FoleyManometer with 35 ml reservoir,
and a FoleyManometer low volume (FoleyManometerLV) with less than 10 ml priming volume.
Measurements and results: Four consecutive time periods of 24 months were defined and compared with
regard to IAP measurement: period 1 (2000-2001), during which IAP monitoring was not used routinely (which
serves as a control group), was compared with period 2 (2002-2003), using a modified homemade technique;
period 3 (2004-2005), introducing the FoleyManometer; and finally period 4 (2006-2007), in which the
FoleyManometerLV was introduced. The incidence of IBP measurements increased from 1.4% in period 1 to 45.4%
in period 4 (p < 0.001). At the same time, the Simplified Acute Physiology Score (version 2) (SAPS-II) increased
significantly from 24.4 ± 21.5 to 34.9 ± 18.7 (p < 0.001) together with the percentage of ventilated patients from
18.6% to 40.7% (p < 0.001). In total, 1,097 patients had IAP measurements via the bladder. The UTI rates were
adjusted for disease severity by multiplying each crude rate with the ratio of control versus study patient SAPS-II
probability of mortality. Crude and adjusted UTI rates per 1,000 catheter days (CD) were on average 16.1 and 12.8/
1,000 CD, respectively, and were not significantly different between the four time periods.
Conclusions: Intrabladder pressure monitoring as estimate for IAP either via a closed transducer technique or the
closed FoleyManometer technique seems safe and does not alter the risk of UTI in critically ill patients.
Introduction
Intra-abdominal hypertension (IAH) and abdominal
compartment syndrome (ACS) have been shown to con-
tribute to organ dysfunction and mortality in critically
ill patients. Diagnosis relies on intra-abdominal pressure
(IAP) measurement, as clinical estimation and abdom-
inal perimeter are poorly correlated with the actual IAP
[1-5].
Different techniques have been developed, either mea-
suring IAP directly or indirectly (via stomach, bladder,
rectum, or inferior vena cava) [2,6-8]. Intrabladder pres-
sure (IBP) monitoring is considered the method of
choice for indirect IAP measurement due to its accuracy
and relative ease [9-11]. IBP is measured through the
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provided the original work is properly cited.patient’s indwelling urinary Foley catheter, utilizing the
bladder wall as a passive transducing membrane.
Although the benefits of IBP monitoring in the diag-
nosis, prevention, and management of IAH/ACS have
been demonstrated, some clinicians remain reluctant to
institute this monitoring technique out of concern for
increasing the patient’s risk of device-related nosocomial
urinary tract infection (UTI) [12]. There are only few
scientific data to support or refute this theory. Chea-
tham et al. published a retrospective study about the
risk of UTI in relation to IBP monitoring using a closed
transducer technique, and he concluded that IBP moni-
toring did not increase the risk of UTI in 122 patients
[12]. Ejike et al. found similar results in a prospective
observational study in critically ill children [13]. On the
contrary, Duane et al. demonstrated a greater risk of
UTI with bladder pressure measurements, this time
using an open technique [14]. The FoleyManometer
(Holtech Medical, Charlottenlund, Denmark, http://
www.holtech-medical.com) is a relatively new device for
IBP measurement using the height of the urine column
as IAP estimate, with the advantage that it does not
require a pressure transducer and can be used outside
the ICU [15]. Because the device uses the patient’so w n
freshly produced urine to measure IAP and not saline
like the other techniques do, t h er i s ko fd e v i c e - r e l a t e d
UTI could either be higher (by the fact that urine is re-
introduced) or lower (since freshly produced urine is by
definition sterile, the FoleyManometer is a closed system
and less manipulations are needed). To our knowledge,
there are no published data so far on the incidence of
UTI using the FoleyManometer. The results of this
study were presented as an oral presentation at the 4th
World Congress for the Abdominal Compartment Syn-




This is a retrospective cohort study conducted on the
electronic patient files of all 5,890 patients admitted to
the 12-bed medical ICU of a tertiary hospital (Zieken-
huis Netwerk Antwerpen, ZNA Stuivenberg Hospital,
Antwerp, Belgium) during an 8-year period stretching
from January 2000 to December 2007. Using the electro-
nic ICU patient database (developed with FileMaker Pro
7.0 software, FileMaker, Inc., Santa Clara, CA, USA),
patient demographics, number of mechanical ventilation
days, urinary catheter days (CD), number of IBP mea-
surements, and patient outcome were collected. Severity
of illness was evaluated using the Simplified Acute Phy-
siology Score (version 2) (SAPS-II). Patient data were
accessed via the database program and exported to an
E x c e lw o r k s h e e t( M i c r o s o f t ,R e d m o n d ,W A ,U S A ) .A l l
patients were cultured according to the standing ICU
protocol. The study was approved by the local institu-
tional review board without need for informed consent
due to the retrospective nature of the analysis.
Intrabladder pressure measurements
According to the number of patients with IAP monitor-
ing and the used IAP measurement technique, the
8-year period could be divided into four distinct time
periods. Initially, only some patients showing one of the
symptoms of elevated IAP (e.g., abdominal distension,
hypercapnia, hypoxemia refractory to increasing inspired
oxygen fractions, and positive end-expiratory pressure,...)
or patients in which the attending physician had a suspi-
cion of elevated IAP without any other symptoms
underwent IBP monitoring (period 1, 2000-2001). This
period in which IAP was measured in 28 out of 2,046
patients served as the control group. Later, in period 2
(2002-2003), IBP monitoring was done more systemati-
cally resulting in the measurement of IAP in all
mechanically ventilated patients from the beginning of
2004. The IBP was then measured every 8 h. In period 2
( a sw e l la st h ef e wp a t i e n t si np e r i o d1 ) ,am o d i f i e d
Cheatham technique (with a closed stopcock system and
instillation of 50 ml sterile saline in the bladder) was
used to measure IAP (Figure 1). This technique has
been described into detail previously [3]. In period 3
(2004-2005), the FoleyManometer with a 35-ml reservoir
(Holtech Medical, Charlottenlund, Denmark, http://
www.holtech-medical.com) was introduced as the stan-
dard technique, and finally, in period 4 (2006-2007), the
newer version FoleyManometer Low Volume (FoleyMa-
nometerLV, Holtech Medical, Charlottenlund, Denmark,
http://www.holtech-medical.com), with less than 10-ml
infusion volume, was used in all patients (Figure 2).
The standard Foley catheter used was the 14-Fr Bard
Biocath (CR Bard, Medical Division, Covington, GA,
USA). Urine drainage tubing, collection bags, and Foley-
Manometers were replaced every 7 days.
Definitions
Urine analysis and urine cultures (UC) were obtained two
times a week (standard on Monday and Thursday) from
mechanically ventilated patients and additionally in any
patient that developed a fever of > 38.5°C or macroscopi-
cally grossly purulent urine. As previously described by
Cheatham, UTI was defined by microbiological culture
documentation of more than 100,000 colony-forming
units per high power field of either a specific bacterium
or fungus together with significant pyuria defined as
either more than five leucocytes per high power field or
more than 25 leucocytes per microliter. Infection rates
were calculated using the Centers for Disease Control
National Nocosomial Infections Surveillance System
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Page 2 of 9Figure 1 Modified method for intrabladder pressure monitoring as described by Malbrain (adapted from [3]with permission).S e t u p :-
Using sterile scissors, the drainage tubing is cut 40 cm after the culture aspiration port after desinfection. - A ramp with three stopcocks is
connected to a conical connection piece at each side with a male/male adaptor and inserted. - A standard intravenous (IV) infusion set is
connected to a bag of 500 ml of saline and attached to the first stopcock. - A 60-ml syringe is connected to the second stopcock, and the third
stopcock is connected to a pressure transducer via rigid pressure tubing. - The system is flushed with normal saline. Method of measurement: -
Patient in supine position. - Zero pressure module at the midaxillary line at the level of the iliac crest (mark for future reference) by turning the
proximal stopcock onto the air and the transducer. - At rest, the three stopcocks are turned ‘off’ to the IV bag, the syringe, and transducer giving
an open way for urine to flow into the urometer - To measure IBP, the urinary drainage tubing is clamped distal to the ramp, and the third
stopcock is turned ‘on’ to the transducer and the patient - The first stopcock is turned ‘off’ to the patient and ‘on’ to the IV infusion bag; the
second stopcock is turned ‘on’ to the IV bag and the 60-ml syringe. - Aspirate 20-25 ml of saline from the IV bag into the syringe. - The first
stopcock is turned ‘on’ to the patient, and the 20-25 ml of normal saline is instilled in the bladder - The first and second stopcocks are then
turned ‘on’ to the patient and thus turned ‘off’ to IV tubing and the syringe. - The third stopcock already being turned ‘on’ to the transducer
and patient allows then immediate IBP reading on the monitor.
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Figure 2 Intrabladder pressure monitoring with the FoleyManometerLV. This technique that uses the patient’so w nu r i n ea sp r e s s u r e
transmitting medium is a simple, reliable, and cost-effective clinical tool. Based on a modified version of the IAP monitoring technique described
by Malbrain [3], the disposable FoleyManometer provides a closed sterile circuit which connects between the patient’s Foley catheter and the
urine collection device. Each IAP determination takes about 10 s, and no subsequent correction of urine output is required. The technique uses a
low bladder infusion volume, has a needle-free sampling port, and can measure IAP in a range from 0 to 40 mmHg. A Initial setup: - Open the
FoleyManometer LV pouch and close the tube clamp. - Place the urine collection device under the patient’s bladder and tape the drainage tube
to the bed sheet. - Insert the FoleyManometer between catheter and drainage device. - Prime the FoleyManometer with 20 ml of sterile saline
through its needle-free injection/sampling port. - Prime only once at initial setup B Urine drainage: - Let the urine drain in between IBP
measurements. - Urine sampling from the needle-free port is facilitated by temporarily opening the red clamp. Remember to close clamp
afterward. - Avoid a U-bend of the large urimeter drainage tube (which will impede urine drainage). - Replace the FoleyManometer whenever
the Foley catheter or the urine collection device is replaced, or at least every 7 days. C Intravesical pressure monitoring: - Place the ‘0-mmHg’
mark of the manometer tube at the midaxillary line at the level of the iliac crest (mark for future reference) and elevate the filter vertically above
the patient. - Open the bio-filter clamp and read IBP (end-expiration value) when the meniscus has stabilized after about 10 s. - Close clamp
after IBP measurement and place the FoleyManometer in its drainage position.
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patient had a urinary catheter in place (or > 12 h portion
thereof) was considered to be one ‘catheter day’.S i n c e
virtually all patients had a Foley in place during their
ICU stay, the number of CD was considered equal to the
number of ICU days. Data were collected on the total
number of UC taken as well as the number of UC per
patient, since one can assume that the more UC are
taken, the more likely the chance that a positive UC will
be identified. The crude UTI risk was defined as the
chance of identifying a positive UC, or thus the number
of UTI divided by the total number of patients. The
adjusted UTI risk was defined as the number of UTI
divided by the number of UC taken. Infection rates are
reported as the number of infections per 1,000 CD. For
statistical analysis, period 1 was used as a control group
(since the incidence of IAP measurement was only 1.4%
and the other periods were compared to each other and
the control group). The crude UTI rate was defined as
the number of UTI/period/1,000 CD, and this was ana-
lyzed in relation to the 1,097 patients that underwent
IAP measurements. The UTI rates were then adjusted for
disease severity, and the adjusted UTI rate was defined as
the crude UTI rate multiplied by the ratio of control
(group 1) versus study (groups 2-4) patients SAPS-II
probability of mortality and compared using the z-
approximation for independent proportions.
Statistical analysis
Descriptive statistics are presented as mean ± standard
deviation. Dichotomous variables were compared using
the chi-squared test, while continuous variables were
compared using Student’s t test. Statistical significance
was defined at two-tailed p value levels of 0.05.
Results
Between January 2000 and December 2007, 5,890
patients were admitted to the medical intensive care
unit; in 1,097 (18.6%) of these patients, IBP was moni-
tored as estimate for IAP. Data regarding patient demo-
graphics, severity of illness, and outcome during the
four periods are presented in Table 1. The number of
patients admitted decreased significantly over the four
periods while mean ICU length of stay increased from
4.1 to 7.1 days. Severity of illness, number of mechanical
ventilation days, and mortality significantly increased
over the four periods (p < 0.001).
Data regarding the crude and adjusted rate of UTI in
the different periods are shown in Table 2. The total
number of UC taken and the number of cultures per
patient increased from 915 to 1,896 and from 0.5 to 1.7,
respectively. The number of positive UC as a ratio to the
number of UC taken decreased in period 4 as compared
to the control group from 12.5% to 9% (p = 0.007).
Overall, the probability to identify a UTI per patient
studied (or thus the crude UTI risk) was on average
8.2% but increased significantly in periods 3 and 4
(10.5% and 12.7%, respectively), when compared to the
5% in the control group (p = 0.039 and p = 0.035,
respectively). The adjusted UTI risk, also taking into
account the number of UC taken, however decreased in
period 4 (7.4%) compared to the other periods and the
control group (11.1%), resulting in non-significant differ-
ences between the four time periods.
The crude UTI rate per 1,000 CD was on average 16.1
but was significantly higher in periods 3 (17.5) and 4
(19.6) when compared to the control (12.7) group (p =
0.007 and < 0.001, respectively). However, the severity
adjusted UTI rate per 1,000 CD was on average 12.8
and was not significantly different between the four
time periods.
The pathogens identified in the 608 positive UC were
predominantly enterobacteriaceae, enterococci, non-fer-
menters, and, rarely, staphylococci, as shown in Figure 3.
In 2004, a local epidemic with enterobacteriaceae was
noted not only in urine cultures but also in endobron-
chial/tracheal aspirates and blood cultures.
Discussion
IAP has gained interest in a wide variety of patient
populations since IAH and ACS have been recognized
as a major cause of potentially life-threatening end-
organ dysfunction. As IAP increases, the physiology of
multiple organ systems is affected leading to inadequate
organ perfusion and tissue oxygenation, multiple organ
failure, and death. IBP monitoring has been recom-
mended by the World Society on Abdominal Compart-
ment Syndrome http://www.wsacs.org as the method of
choice for indirect measurement of IAP due to its accu-
racy and relative ease of measurement [10,11].
The original method for IBP monitoring was described
by Kron and co-workers and required the patient’s urin-
ary catheter to be disconnected [18]. This leads to justi-
fied fears for device-related UTI. The modified
technique proposed by Cheatham still used sterile saline
instillation into the bladder but maintained the patient’s
urinary catheter as a closed system, which put to rest
some of the concerns relating to UTI [19]. The Foley-
Manometer is also a closed sterile system but uses
freshly produced urine as IAP transmitting medium and
measures the height of the fluid/urine column in an
especially designed drainage tube with a 35-ml reservoir.
After several reports stating that lower instillation
volumes can and should be used for IBP measurements
in order to avoid overestimation of IAP, a new FoleyMa-
nometerLV was designed with less than 10-ml infusion
volume [11,20,21]. The re-instillation of the patient’s
own urine which may have been in the drainage tube
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for UTI than the previous IBP measurement techniques.
Our study is, to our knowledge, the first to examine the
risk for UTI using urine as a transmitting medium for
IBP measurement.
Before this publication, Cheatham et al. published
already a study on UTI risk in relation to IBP monitor-
ing using other devices [12]. They found that IBP moni-
toring using a closed transducer technique with sterile
saline instillations is safe and does not increase the risk
of UTI. Ejike et al. found similar results in a prospective
observational study in critically ill children, also using a
closed technique with sterile saline installations [13]. On
the other hand, Duane et al. demonstrated a greater risk
of UTI with bladder pressure measurements using an
open technique in which the Foley catheter was com-
promised through insertion of an 18-gauge needle and
disconnection of the Foley catheter to allow instillation
of 50 ml of saline into the bladder [14]. We confirmed
that the UTI rate, when adjusted for disease severity,
remained unchanged with or without IBP monitoring
using different devices, all being closed systems. There
was a trend toward higher adjusted UTI rates using the
FoleyManometer with larger instillation volumes that
Table 1 Demographic data







2000-2001 2002-2003 2004-2005 2006-2007
Patients (n) 2,046 1,480 1,261 1,103 5,890 -
Age (years) 66 ± 17.5 65 ± 16.2 65 ± 16.3 63 ± 18.7 65 ± 17.1 NS
SAPS-II 24.4 ± 21.5 30.1 ± 20.4 32.4 ± 18.7 34.9 ± 18.7 29.8 ± 20.4 < 0.001
ICU days 8,045 7,265 7,584 7,161 30,055 -
MV days 2,988 3,343 3,192 3,785 13,308 -
%MV (days) 37.1% 46% 42.1% 52.9% 44.32% < 0.001
IAP patients 28 (1.4%) 146 (9.9%) 422 (33.5%) 501 (45.4%) 1,097
(18.6%)
< 0.001
MV patients 381 (18.6%) 404 (27.3%) 418 (33.1%) 449 (40.7%) 1,652
(28.1%)
< 0.001
ICU stay (days) 4.1 ± 7.3 4.3 ± 7.6 5.1 ± 8.7 7.1 ± 16.6 5.3 ± 11 < 0.001
Predicted
mortality
16.5% ± 23.8 20.5% ± 25 21.2% ± 25.6 24.3% ± 26.3 20.1% ±
25.2
< 0.001
ICU mortality 11% 12.7% 15.2% 17.4% 13.5% < 0.001
Severity of illness and outcome of critically ill patients during the four time periods. IAP, intra-abdominal pressure; ICU, intensive care unit; MV mechanical
ventilation; SAPS, Simplified Acute Physiology Score.
Table 2 Risk and rate of urinary tract infections during the four study periods
Period 1 Period 2 Period 3 Period 4 Total
Control group Modified Cheatham technique FoleyManometer FoleyManometerLV
2000-2001 2002-2003 2004-2005 2006-2007
UC 915 1,062 1,568 1,896 5,441
UC/patient 0.4 0.7 1.2 1.7 0.9
POS UC 114 119 204 171 608
POS UC/UC sample, % 12.5 11.2 13 9* 11.2
UTI 102 106 133 140 481
UTI risk (CR), % 5.0 7.2 10.5 12.7° 8.2
UTI risk (ADJ), % 11.1 10.0 8.5 7.4 8.8
UTI/1,000 CD (CR) 12.7 14.6 17.5
§ 19.6
# 16.1
UTI/1,000 CD (ADJ) 12.7 11.7 13.6 13.3 12.8
ADJ, adjusted; CD, catheter days; CR, crude rate; POS, positive (bacteriuria); UC, urine culture; UTI, urinary tract infection = positive UC with more than five
leucocytes per high power field or more than 25 leucocytes per microliter; UTI risk (CR), the number of UTI divided by the total number of patients; UTI risk
(ADJ), the number of UTI divided by the number of UC taken; UTI/1,000 CD (CR), the number of UTI/period/1,000 CD; UTI/1,000 CD (ADJ), the crude UTI rate
multiplied by the ratio of control (group 1) versus study (groups 2-4) patients SAPS-II probability of mortality. *p value 0.007, 0.06, and < 0.001 when period 4
was compared to period 1 (control), period 2 and period 3, respectively, regarding number of positive UC with regard to total number of UC; °p value 0.039 and
0.035 when period 4 was compared to period 1 and 2, respectively;
#p value < 0.001 and 0.011 when period 4 was compared to period 1 and 2, respectively;
§p
value 0.007 when period 3 was compared to period 1.
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significant when compared to the other groups. With
the newer FoleyManometerLV, the trend toward higher
adjusted UTI rates disappeared, and thus, this is a safe
technique.
The UTI rates per 1,000 CD reported in this study are
higher than those reported by Cheatham who found
10.4 crude and 7.9 adjusted UTI/1,000 CD in the patient
population that underwent IAP monitoring versus 6.5 in
the control group. We observed 12.7 in our control
group, and this could be related to the fact that CD in
o u rs t u d yc o i n c i d e dw i t hI C Us t a y ,s oi tc o u l db ep o s s i -
ble that some patients kept their Foley catheters after
ICU discharge leading to actual longer CD (that were
not taken into account) and thus overestimation of UTI
risk. In a large study on 2,644 ICU patients, van der
Kooi et al. found a UTI incidence of 8% (versus 8.8% in
our study) and 9 UTI/1,000 CD (versus 16.1 crude and
12.8 adjusted in our study) [22]. In another study on
337 adult ICU patients, the crude risk for UTI was 14/
1,000 CD, which is close to what we observed [23].
O n ec o u l ds t a t et h a tt h em o r eU Ct a k e n ,t h eg r e a t e r
the chance of identifying a positive UC. But although
the total number of UC taken and thus the number of
UC per patient increased during our observation, there
was no increase in the UTI rates during period 4.
The strong points of our study, although still retro-
spective and purely observational in nature, are the pre-
sence of a historic control group, allowing comparison
of subsequent groups versus a ‘baseline’ UTI rate, and,
more importantly, the standardized approach to both
IAP monitoring and urine sampling. IAP monitoring is
used in all mechanically ventilated patients in our ICU,
and cultures are taken at least twice a week or more fre-
quently if clinically indicated.
There are also some important and obvious limita-
tions to our study. First of all, there is the retrospective
design leading to missing data on antibiotic use and
Figure 3 Evolution of pathogens identified in urine cultures during the different time periods. EB, enterobacteriaceae; NF, non-fermenters
(e.g., pseudomonas); Staph, staphylococci; Entero, enterococci.
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our patient population evolved significantly over the 8-
year time period. Disease severity (SAPS-II score), ICU
length of stay, number of ventilation days, and ICU
mortality increased significantly over the four time peri-
ods. To correct for this evolution, crude UTI rates were
adjusted for disease severity, but naturally, this does not
correct for all possible sources of bias in the study.
Third, potential etiological factors for the development
of IBP monitoring-associated UTI were not considered.
The duration of urinary catheterization could be differ-
ent in the four groups, although this was determined by
the standard ICU procedures as stated in the methods
(urine drainage tubing, collection bags, and FoleyMan-
ometers were replaced every 7 days). Fourth, due to the
epidemiologic and observational nature of the study
looking at global incidences, we could not look for indi-
vidual factors predictive for UTI or outcome by multiple
logistic regression analysis.
Conclusion
In summary, IBP monitoring with a closed transducer
technique or with the FoleyManometerLV, as estimate
for IAP, does not have an influence on the risk of UTI
in critically ill patients.
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